FIBROLAMELLAR
CANCER FOUNDATION
We are here to help.
FIBROLAMELLAR
CANCER FOUNDATION
We are here to help.
Announcements
- Free treatment and clinical trial access. Did you realize the National Cancer Institute offers free consultation, treatment and travel for fibrolamellar (FLC) patients? Dr. Tim Greten, MD spearheads the NCI’s fibrolamellar efforts and is available to speak with anyone in our community interested in learning more. Besides offering tailored treatment for each patient per consultation, there are also two clinical trials […]
- October 1 is Rare Cancer Day Tuesday October 1, 2019 is Rare Cancer Day. This year is especially important because at the Fibrolamellar Cancer Foundation (FCF) we are celebrating 10 years of bringing awareness to this disease. We are proud to have contributed nearly 8 million dollars to researching cures and treatments for this horrific disease. Despite the fact that […]
- Important U of Washington study published FLC tumors contain a unique genetic defect that fuses together portions of genes called DNAJ and PKAc. DNAJ helps fold other proteins into their correct shapes, whereas PKAc is an enzyme involved in cell communication. An FCF supported research team at the University of Washington, Seattle now report that the DNAJ-PKAc fusion additionally recruits […]
- St. Jude Children’s Research Hospital and University of Tennessee co-host major fibrolamellar research collaboration summit focused on immunotherapy The summit brought together some of the most innovative researchers, clinicians and funders serving the FLC community, including Johns Hopkins, Rush University, University of Maryland, along with co-hosts St. Jude Children’s Research Hospital and U of Tennessee and The Fibrolamellar Cancer Foundation. The meeting highlighted many of the latest discoveries in FLC immunotherapy which were […]
